The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor

Published:2010-10-01 Issue:10 Volume:5 Page:e13128
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

O'Donnell Edmond F.,Saili Katerine S.,Koch Daniel C.,Kopparapu Prasad R.,Farrer David,Bisson William H.,Mathew Lijoy K.,Sengupta Sumitra,Kerkvliet Nancy I.,Tanguay Robert L.,Kolluri Siva Kumar

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy;Current Cancer Drug Targets;2024-11

2. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022);Recent Patents on Anti-Cancer Drug Discovery;2024-08

3. Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML;Journal of Medicinal Chemistry;2024-06-18

4. The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation;Biomolecules;2024-04-04

5. Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP